The Utility of Esophageal Motility Testing in Gastroesophageal Reflux Disease (GERD)

被引:10
作者
Garbarino S. [1 ]
Horton A. [1 ]
Patel A. [1 ]
机构
[1] Division of Gastroenterology, Duke University School of Medicine and the Durham Veterans Affairs Medical Center, 10207 Cerny St, Suite 210, Raleigh, 27617, NC
关键词
Achalasia; Antireflux surgery (ARS); Esophageal function testing; Esophageal high-resolution manometry (HRM); Esophageal motor testing; Gastroesophageal reflux disease (GERD); High-resolution impedance manometry (HRIM); Multiple rapid swallows (MRS);
D O I
10.1007/s11894-019-0704-7
中图分类号
学科分类号
摘要
Purpose of Review: Here, we discuss how esophageal motor testing plays important roles in patients with suspected gastroesophageal reflux disease (GERD). In addition to guiding appropriate placement of catheters for ambulatory reflux monitoring, esophageal high-resolution manometry (HRM) rules out confounding diagnoses, such as achalasia spectrum disorders, that can present with symptoms similar to that of GERD, but are managed very differently. Recent Findings: HRM performed with impedance in the post-prandial setting (PP-HRIM) can assess for rumination syndrome or supragastric belching, which should be directed towards behavioral interventions. The recent GERD Classification of Motor Function recommends a hierarchical approach, focusing on (1) the esophagogastric junction (EGJ), (2) the esophageal body, and (3) esophageal contraction reserve, which can be assessed with provocative maneuvers at HRM, such as multiple rapid swallows (MRS). This approach can inform the appropriate tailoring of antireflux surgery. Novel esophageal motility metrics, such as the EGJ-contractile integral from HRM, or post-reflux swallow-induced peristaltic wave indices from 24-h pH-impedance monitoring, may also assist with GERD diagnosis. Summary: Assessment of esophageal motor function can contribute in a significant manner to the care of patients with suspected GERD, particularly when esophageal symptoms do not improve with antisecretory therapy, and/or when surgical or endoscopic antireflux therapies are under consideration. © 2019, Springer Science+Business Media, LLC, part of Springer Nature.
引用
收藏
相关论文
共 53 条
[1]  
El-Serag H., Sweet S., Winchester C., Dent J., Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review, Gut, 63, pp. 871-880, (2014)
[2]  
Vakil N., van Zanten S., Kahrilas P., Dent J., Et al., The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus, Am J Gastroenterol, 101, pp. 1900-1920, (2006)
[3]  
Numans M.E., Lau J., de Wit N.J., Bonis P.A., Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics, Ann Intern Med, 140, pp. 518-527, (2004)
[4]  
Katz P., Gerson L., Vela M., Guidelines for the diagnosis and management of gastroesophageal reflux disease, Am J Gastroenterol, 108, pp. 308-328, (2013)
[5]  
Patel A., Gyawali C.P., Gastroesophageal reflux monitoring, JAMA, 319, pp. 1271-1272, (2018)
[6]  
Roman S., Gyawali C.P., Savarino E., Yadlapati R., Zerbib F., Wu J., Vela M., Tutuian R., Tatum R., Sifrim D., Keller J., Fox M., Pandolfino J.E., Bredenoord A.J., Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: update of the Porto consensus and recommendations from an international consensus group, Neurogastroenterol Motil, 29, (2017)
[7]  
Gyawali C.P., Kahrilas P., Savarino E., Zerbib F., Et al., Modern diagnosis of GERD: the Lyon consensus, Gut, 67, pp. 1351-1362, (2018)
[8]  
Gyawali C.P., Roman S., Bredenoord A., Fox M., Et al., Classification of esophageal motor findings in gastro-esophageal reflux disease: conclusions from an international consensus group, Neurogastroenterol Motil, 29, (2017)
[9]  
Gyawali C.P., Patel A., Esophageal motor function: Technical Aspects of Manometry, Gastrointest Endoscopy Clin N Am, 24, pp. 527-543, (2014)
[10]  
Patel A., Posner S., Gyawali C.P., Esophageal high-resolution manometry in gastroesophageal reflux disease, JAMA, 320, pp. 1279-1280, (2018)